Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $255K | +11.2K | +66.59% | $22.89 | 27.9K | Feb 25, 2023 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$93.2K | -2.23K | -8.01% | $41.75 | 25.7K | Feb 25, 2023 | Direct | F2, F3 |
transaction | PFE | Common Stock | Tax liability | -$215K | -4.96K | -19.32% | $43.44 | 20.7K | Feb 25, 2023 | Direct | F4, F5 |
transaction | PFE | Common Stock | Tax liability | -$58.2K | -1.43K | -6.89% | $40.78 | 19.3K | Feb 27, 2023 | Direct | F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -11.2K | -100% | $0.00* | 0 | Feb 25, 2023 | Common Stock | 11.2K | $22.89 | Direct |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F3 | Price is the closing price of Pfizer common stock on February 24, 2023. |
F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F6 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |